| Index date: date of histological diagnosis of OS or ES |
Osteosarcoma VTE % (95% CI) |
Ewing sarcoma VTE % (95% CI) |
Osteosarcoma MB % (95% CI) |
Ewing sarcoma MB % (95% CI) |
|---|---|---|---|---|
| 3 months | 5.2 (3.5–7.3) | 1.8 (0.50–4.8) | 1.2 (0.48–2.4) | 0 |
| 6 months | 6.7 (4.8–9.1) | 1.8 (0.50–4.8) | 2.3 (1.3–3.9) | 0.61 (0.06–3.1) |
| 9 months | 7.5 (5.4–10) | 4.2 (1.9–8.1) | 2.5 (1.4–4.1) | 0.61 (0.06–3.1) |
| 12 months | 8.3 (6.1–11) | 6.1 (3.1–10) | 3.3 (2.0–5.1) | 1.2 (0.24–4.0) |
| 24 months | 8.8 (6.6–11) | 6.7 (3.5–11) | 4.0 (2.6–6.0) | 2.5 (0.81–5.8) |
OS: osteosarcoma; ES: Ewing sarcoma; VTE: venous thromboembolism; MB: major bleeding; CI: confidence interval
Adjusted cumulative incidence: cumulative incidence adjusted for competing risk of death (following the CICR method).